Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Apyx Medical (APYX) Accumulated Depreciation & Amortization (2016 - 2025)

Apyx Medical filings provide 15 years of Accumulated Depreciation & Amortization readings, the most recent being $4.1 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 23.17% to $4.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.1 million, a 23.17% increase, with the full-year FY2025 number at $4.1 million, up 23.17% from a year prior.
  • Accumulated Depreciation & Amortization hit $4.1 million in Q4 2025 for Apyx Medical, up from $3.4 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $4.1 million in Q4 2025 to a low of $157000.0 in Q1 2024.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $506000.0 (2022), compared with a mean of $891437.5.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: fell 25.0% in 2023 and later surged 384.68% in 2024.
  • Apyx Medical's Accumulated Depreciation & Amortization stood at $903000.0 in 2021, then dropped by 1.44% to $890000.0 in 2022, then decreased by 22.25% to $692000.0 in 2023, then surged by 384.68% to $3.4 million in 2024, then increased by 23.17% to $4.1 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $4.1 million (Q4 2025), $3.4 million (Q4 2024), and $313000.0 (Q2 2024) per Business Quant data.